Study of Podocalyxin as an Identifying Marker of Leukemic Blast Cells in Acute Myeloid Leukemia

Zaynab Mustafa Mohamed Slim;

Abstract


AML describes a heterogenous group of hematological disorders characterized by block in the terminal differentiation of particular hemopoietic cell lineage. The accurate diagnosis of AML is important for appropriate treatment and management. Flow cytometr


Other data

Title Study of Podocalyxin as an Identifying Marker of Leukemic Blast Cells in Acute Myeloid Leukemia
Other Titles دراسة البودوكاليكسن كعلامة لتحديد خلايا اللوكيميا في سرطان الدم النقوى الحاد
Authors Zaynab Mustafa Mohamed Slim
Keywords Study of Podocalyxin as an Identifying Marker of Leukemic Blast Cells in Acute Myeloid Leukemia
Issue Date 2011
Description 
AML describes a heterogenous group of hematological disorders characterized by block in the terminal differentiation of particular hemopoietic cell lineage. The accurate diagnosis of AML is important for appropriate treatment and management. Flow cytometr

Attached Files

File SizeFormat
107039p4414.pdf2.11 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.